Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)
- Conditions
- Head and Neck Squamous Cell Carcinomas
- Interventions
- Drug: Tislelizumab（neoadjuvant）Drug: Nab-paclitaxel （neoadjuvant）Procedure: Surgical resectionDrug: Cisplatin（adjuvant）Drug: Tislelizumab（adjuvant）Radiation: Radiation
- First Posted Date
- 2022-10-17
- Last Posted Date
- 2024-05-17
- Target Recruit Count
- 537
- Registration Number
- NCT05582265
- Locations
- 🇨🇳
Zhong shan people's hospital, Zhongshan, Guangdong, China
🇨🇳Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guanzhou, Guangdong, China
🇨🇳Huazhong University of Science and Technology Union Hospital (Nanshan Hospital), Shenzhen, Nanshan, China
Collection of Peripheral Blood Mononuclear Cells From Healthy Subjects
- Conditions
- Disease of the Blood
- First Posted Date
- 2022-09-29
- Last Posted Date
- 2022-09-29
- Target Recruit Count
- 50
- Registration Number
- NCT05560217
Nipple-sparing Mastectomy in Combined With Buried Flap Monitoring
- Conditions
- Breast/Surgery
- First Posted Date
- 2022-09-29
- Last Posted Date
- 2022-09-29
- Target Recruit Count
- 147
- Registration Number
- NCT05560633
A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs
- Conditions
- Breast CancerTriple-Negative Breast Cancer
- Interventions
- Drug: Anti-PD-1 monoclonal antibodyDrug: VEGFR2 Tyrosine Kinase Inhibitor
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2023-04-12
- Target Recruit Count
- 58
- Registration Number
- NCT05556200
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
🇨🇳The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
🇨🇳Second Military Medical University, Shanghai, Shanghai, China
Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2022-09-28
- Target Recruit Count
- 43
- Registration Number
- NCT05550558
TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2022-09-22
- Target Recruit Count
- 26
- Registration Number
- NCT05550025
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangzhou, China
Effect of Dapagliflozin on VT in Patients With Heart Failure.
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2022-09-22
- Target Recruit Count
- 120
- Registration Number
- NCT05550441
Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2022-09-19
- Target Recruit Count
- 138
- Registration Number
- NCT05545059
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
The Effect of PHGG-rich Enteral Nutrition to on the Infection in Liver Transplant Recipients: A Prospective, Double-blind, Randomized Controlled Study
- Conditions
- Infections
- Interventions
- Drug: PHGG-rich enteral nutrtiion
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2022-09-16
- Target Recruit Count
- 136
- Registration Number
- NCT05543226
Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation on Radiotherapy-Related Neuropathic Pain
- Conditions
- Neuropathic PainRadiotherapy Side Effect
- Interventions
- Device: Sham Transcutaneous Auricular Vagus Nerve Stimulation(SS)Device: Transcutaneous Auricular Vagus Nerve Stimulation(TaVNS)
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2022-10-12
- Target Recruit Count
- 116
- Registration Number
- NCT05543239
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
🇨🇳Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, China
🇨🇳Department of Nasopharyngeal Carcinoma, The Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China